iBio Inc (NYSEAMERICAN: IBIO) is making a run for the top in the market this morning, trading on gains of more than 6% early on. While the stock is up, it hasn’t issued any press releases or SEC filings. So, what’s the deal? Stop wasting your time! Start finding winning trades in minutes with Trade … Read more
iBio Inc (NYSEAMERICAN: IBIO) has been a hot topic as of late. After announcing a collaboration with CC Pharming to develop a vaccine for the Wuhan coronavirus, the stock started to soar. However, before the run, the company was in trouble. A detrimentally low trading price was threatening delisting and harming the company’s ability to … Read more
iBio, Inc. (NYSEAMERICAN: IBIO) is flying early on in the trading session this morning, and for good reason. The company announced the commencement of a strategic commercial relationship that’s clearly a point of exitement for investors. Today, we’ll talk about: The new relationship; what we’re seeing from IBIO as a result; and what we’ll be … Read more
iBio Inc (NYSEAMERICAN: IBIO) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced the expansion of its capabilities and services. Of course, this news led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about the news, what we’re seeing from … Read more
Ibio Inc (NYSEMKT: IBIO) is having an overwhelmingly strong day in the market today, and for good reason. The company provided an intellectual property update early this morning that’s causing excitement among investors who are pushing the stock toward the top. As is nearly always the case, our partners at Trade Ideas were the first … Read more
Ibio Inc (NYSEMKT: IBIO) In very rare cases, I like to take a look at stocks that trade for under a dollar per share to see if they are providing solid opportunities. Today, I decided to look into Ibio; I was glad I did. While Ibio is still trading for pennies, it seems as though the … Read more
iBio Finds Gains On Positive Data iBio INC (NYSEMKT: IBIO) iBio is having a great day in the market today after announcing that Dr. Feghali-Bostwick made a new discovery that proves to be an extension of the doctor’s previous discovery. Dr. Feghali-Bostwick previously found that a peptide derived from endostatin can prevent or ameliorate fibrosis … Read more
iBio Inc (NYSEMKT: IBIO) iBio is having a great day in the market today after announcing new discoveries found by iBio’s scientific collaborator, Carol Feghali-Bostwick, Ph.D. Today, we’ll take a look at the new discoveries found, how the market reacted to the news, and what we can expect to see from the stock moving forward. … Read more
AVEO Pharmaceuticals Stock Climbs On Licensing Agreement AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) AVEO announced today that it has entered into an exclusive, worldwide license agreement with Novartis for it’s first-in-class, potent, humanized inhibitory antibody targeting growth differentiation factor 15. The antibody is known as AV-380 and the agreement also includes related antibodies as well as … Read more
iBio Inc (NYSEMKT: IBIO) Last week proved to be an incredible week for iBio after the company announced that it had received a notice from the US patent office letting them know that their patent had been approved. Today, we’ll talk about the patent that created all the hype, what we’re seeing in the market … Read more